ImmunoScape’s Andreas Wilm offers a behind the scenes look at the machine learning models we trained for research published in Cell Press’ Cell Reports – which validated ImmunoScape’s platform by accurately predicting T-cell antigen specificity through phenotypic data alone. Wilm, an architect of ImmunoScape’s platform, digs into how researchers used ML predictions to confirm antigen specificity through in vitro testing. This data will be leveraged to discover and develop next-generation TCR therapeutics. Read more below.
A behind the scenes look at the machine learning platform
November 4, 2023